Literature DB >> 2612518

The disposition of SK&F L-94901, a selective thyromimetic in rat, dog and cynomolgus monkey.

M A Pue1, J A Ransley, D J Writer, A J Dean, E R Franklin, I G Beattie, D A Ross.   

Abstract

SK&F L-94901 is a novel thyromimetic, structurally related to thyroxine. The absorption, distribution, excretion and metabolism of radiochemically labelled [14C]-SK&F L-94901 has been investigated in the rat, dog and cynomolgus monkey. Oral absorption from solution was low or moderate in all three species. The compound was widely distributed and rapidly excreted, although traces of radioactivity were still evident in some tissues at 7 days post-dose, particularly in the kidney where radioactivity was located in an area approximating to the corticomedullary junction. Elimination of [14C]-SK&F L-94901 was both metabolic, mediated by the liver, and renal. The major metabolic routes of elimination were via oxidative deamination to lactate and acetate derivatives.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2612518     DOI: 10.1007/BF03190101

Source DB:  PubMed          Journal:  Eur J Drug Metab Pharmacokinet        ISSN: 0378-7966            Impact factor:   2.441


  13 in total

1.  3,3',5'-TRIIODOTHYRONINE AND 3,3'-DIIODOTHYRONINE: PARTIALLY DEIODINATED INTERMEDIATES IN THE METABOLISM OF THE THYROID HORMONES.

Authors:  E V FLOCK; C DAVID; G H STOBIE; C A OWEN
Journal:  Endocrinology       Date:  1963-10       Impact factor: 4.736

2.  Metabolism of thyroxine during prolonged kidney cortex incubation.

Authors:  N ETLING; S B BARKER
Journal:  Endocrinology       Date:  1959-05       Impact factor: 4.736

3.  Enzymatic conversion of thyroxine to tetraiodothyroacetic acid and of triiodothyronine to triiodothyroacetic acid.

Authors:  E C ALBRIGHT; H A LARDY; F C LARSON; K TOMITA
Journal:  J Biol Chem       Date:  1957-01       Impact factor: 5.157

4.  A technique for chronic intermittent bile collection from the rat.

Authors:  J K Chipman; N C Cropper
Journal:  Res Vet Sci       Date:  1977-05       Impact factor: 2.534

5.  A thyromimetic that decreases plasma cholesterol levels without increasing cardiac activity.

Authors:  A H Underwood; J C Emmett; D Ellis; S B Flynn; P D Leeson; G M Benson; R Novelli; N J Pearce; V P Shah
Journal:  Nature       Date:  1986 Dec 4-10       Impact factor: 49.962

Review 6.  The metabolism of iodothyronines in health and disease with special reference to diiodothyronines.

Authors:  J Faber
Journal:  Dan Med Bull       Date:  1984-08

7.  Biliary excretion of iodothyronines in rats as determined by high pressure liquid chromatography: effect of starvation.

Authors:  N A Takai; B Rapoport; M Yamamoto
Journal:  Endocrinology       Date:  1980-07       Impact factor: 4.736

8.  Serum concentration, metabolic clearance, and production rates of 3,5,3'-triiodothyroacetic acid in normal and athyreotic man.

Authors:  L A Gavin; B M Livermore; R R Cavalieri; M E Hammond; J N Castle
Journal:  J Clin Endocrinol Metab       Date:  1980-09       Impact factor: 5.958

9.  The distribution of radioactivity in pregnant rats after repeated oral doses of the diuretic agent Etozolin.

Authors:  E R Franklin; L F Chasseaud; T Taylor
Journal:  Arzneimittelforschung       Date:  1977

10.  The nondeiodinative pathways of thyroxine metabolism: 3,5,3',5-tetraiodothyroacetic acid turnover in normal and fasting human subjects.

Authors:  C S Pittman; T Shimizu; A Burger; J B Chambers
Journal:  J Clin Endocrinol Metab       Date:  1980-04       Impact factor: 5.958

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.